Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200618

FEXOFENADINE HYDROCHLORIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl

Basic Information

ChEMBL ID CHEMBL1200618
Name FEXOFENADINE HYDROCHLORIDE
Phase Approved
Structure Type MOL
InChI Key RRJFVPUCXDGFJB-UHFFFAOYSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL914
Active Moiety CHEMBL914

Known Names

Allegra Allegra allergy Allegra hives Children's allegra allergy Children's allegra hives Children's fexofenadine hydrochloride allergy Children's fexofenadine hydrochloride hives Fexofenadine hcl Fexofenadine hydrochloride Fexofenadine hydrochloride allergy Fexofenadine hydrochloride component of allegra-d Fexofenadine hydrochloride hives +5 more
4
Targets
4
Activities
2
Assay Types
14
PK Parameters
20
Publications
17
Known Names
6
Indications
1
Mechanisms

Molecular Properties

501.7
MW (Da)
5.51
ALogP
4
HBA
3
HBD
81.0
PSA (Ų)
0.34
QED
2
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1996
Availability OTC
Chirality Racemic

Routes of Administration

Oral
USAN Year 1995

Extended Properties

Molecular Formula C32H40ClNO4
MW 538.13
Aromatic Rings 3
Heavy Atoms 37
NP-Likeness -0.33

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Histamine H1 receptor antagonist ANTAGONIST Histamine H1 receptor

Indications

Hypersensitivity Rhinitis, Allergic, Seasonal Rhinitis, Allergic, Seasonal Urticaria Rhinitis, Allergic, Perennial Kidney Calculi

Activity Summary

Ki 3 meas. best 7.03
IC50 1 meas. best 5.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Histamine H1 receptor
CHEMBL231
Ki 7.03 7.03 93.1 1
D(3) dopamine receptor
CHEMBL234
Ki 5.63 5.63 2350.2 1
D(2) dopamine receptor
CHEMBL217
Ki 5.05 5.05 8806.4 1
Plasmodium falciparum
CHEMBL364
IC50 5.0 5.0 10000.0 1

Pharmacokinetic Data

Parameter Value Units Species
Cmax 380.73 nM Homo sapiens
Cmax 508.3 nM Homo sapiens
Cmax 283.05 nM Homo sapiens
Cmax 261.13 nM Homo sapiens
Cmax 984.71 nM Homo sapiens
Cmax 175.41 nM Homo sapiens
Excretion 11.0 % Homo sapiens
Excretion 80.0 % Homo sapiens
T1/2 14.4 hr Homo sapiens
Tmax 2.0 hr Homo sapiens
Tmax 2.0 hr Homo sapiens
Tmax 2.6 hr Homo sapiens
Tmax 2.0 hr Homo sapiens
Tmax 1.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL4689842 HEK-293T 10
25740159 10.1016/j.bmcl.2015.02.013 No relevant target 9
- 10.6019/CHEMBL4689842 Fibroblast 9
- 10.6019/CHEMBL4689842 U2OS 8
- 10.6019/CHEMBL5209801 Type-1 angiotensin II receptor 5
- 10.6019/CHEMBL5209801 Apelin receptor 5
- 10.6019/CHEMBL5209801 N-formyl peptide receptor 2 5
- 10.6019/CHEMBL5209801 Alpha-2A adrenergic receptor 5
- 10.6019/CHEMBL5209801 Glucose-dependent insulinotropic receptor 5
- 10.6019/CHEMBL5209801 Beta-2 adrenergic receptor 5
- 10.6019/CHEMBL5209801 Free fatty acid receptor 4 5
- 10.6019/CHEMBL5209801 C5a anaphylatoxin chemotactic receptor 1 5
- 10.6019/CHEMBL5209801 CX3C chemokine receptor 1 5
- 10.6019/CHEMBL5209801 Sphingosine 1-phosphate receptor 1 5
- 10.6019/CHEMBL5209801 Glucagon-like peptide 1 receptor 5
- 10.6019/CHEMBL5209801 Adhesion G-protein coupled receptor F1 5
- 10.1007/s00044-009-9285-6 Serum 5
- 10.6019/CHEMBL5209801 G-protein coupled receptor 35 2
- 10.6019/CHEMBL5665443 Uracil-DNA glycosylase 1
- 10.6019/CHEMBL4513141 Candida albicans 1

Data from ChEMBL 36 via Core Engine